 H.C. Wainwright analyst Amit Dayal lowered the price target on Aspen Aerogels Inc NYSE: ASPN to 45 an upside of 57.6 from 65 and maintained a Buy rating on the shares. The analyst cites the companys updated outlook stemming from plans for its thermal runaway expansion for the target drop. 